{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:23:05Z","timestamp":1791321785945,"version":"4.3.1"},"reference-count":171,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.berh.2007.06.002","type":"journal-article","created":{"date-parts":[[2007,9,15]],"date-time":"2007-09-15T07:23:54Z","timestamp":1189841034000},"page":"885-906","source":"Crossref","is-referenced-by-count":335,"title":["Comorbidities in rheumatoid arthritis"],"prefix":"10.1016","volume":"21","author":[{"given":"Kaleb","family":"Michaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.rdc.2004.07.007","article-title":"Data collection, maintenance, analysis for rheumatic disease research","volume":"30","author":"Wolfe","year":"2004","journal-title":"Rheumatic Diseases Clinics of North America"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/art.22226","article-title":"Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol","volume":"55","author":"Hern\u00e1ndez-Cruz","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00005650-200411000-00012","article-title":"A comparison of four indirect methods of assessing utility values in rheumatoid arthritis","volume":"42","author":"Marra","year":"2004","journal-title":"Medical Care"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib4","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"Journal of Chronic Diseases"},{"issue":"7\u20138","key":"10.1016\/j.berh.2007.06.002_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0021-9681(74)90017-4","article-title":"The importance of classifying initial co-morbidity in evaluatin the outcome of diabetes mellitus","volume":"27","author":"Kaplan","year":"1974","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","article-title":"A chronic disease score from automated pharmacy data","volume":"45","author":"Von Korff","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005650-199302000-00005","article-title":"The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement","volume":"31","author":"Greenfield","year":"1993","journal-title":"Medical Care"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90005-N","article-title":"Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale","volume":"41","author":"Miller","year":"1992","journal-title":"Psychiatry Research"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jclinepi.2004.10.018","article-title":"The development of a comorbidity index with physical function as the outcome","volume":"58","author":"Groll","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib12","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/ard.2004.034777","article-title":"Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s","volume":"64","author":"Goodson","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"10.1016\/j.berh.2007.06.002_bib13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/art.21932","article-title":"Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis","volume":"54","author":"Van Doornum","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.2006.052456","article-title":"Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis","volume":"66","author":"Sodergren","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2007.06.002_bib15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: rates, predictors, the effect of anti-tumor necrosis factor therapy","volume":"116","author":"Wolfe","year":"2004","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","article-title":"Antirheumatic drug use and the risk of acute myocardial infarction","volume":"55","author":"Suissa","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2003.09.037","article-title":"Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction","volume":"93","author":"Fischer","year":"2004","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib19","first-page":"1196","article-title":"All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database","volume":"30","author":"Watson","year":"2003","journal-title":"The Journal of Rheumatology"},{"issue":"18","key":"10.1016\/j.berh.2007.06.002_bib20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"European Heart Journal"},{"issue":"24","key":"10.1016\/j.berh.2007.06.002_bib21","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.berh.2007.06.002_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"The New England Journal Medicine"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/keh610","article-title":"Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis","volume":"44","author":"Bernatsky","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib25","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib26","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"The Journal of Rheumatology"},{"issue":"9","key":"10.1016\/j.berh.2007.06.002_bib27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib28","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/ard.2003.018101","article-title":"Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study","volume":"63","author":"Turesson","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ard.2003.013110","article-title":"Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists","volume":"63","author":"Sany","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9313","key":"10.1016\/j.berh.2007.06.002_bib31","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib32","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/ard.2006.062497","article-title":"Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis","volume":"66","author":"Jacobsson","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib33","first-page":"671","article-title":"Considering cardiovascular mortality in patients with rheumatoid arthritis from a different perspective: a role for autonomic dysregulation and obstructive sleep apnea","volume":"34","author":"Holman","year":"2007","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2007.06.002_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2006.067660","article-title":"All cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with TNF antagonists","author":"Carmona","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9 (supplement)","key":"10.1016\/j.berh.2007.06.002_bib35","first-page":"S229","article-title":"All cause mortality is not increased following the use of Anti-TNF Agents in patients with rheumatoid arthritis: results from a nation-wide prospective study","volume":"52","author":"Watson","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Current Opinion In Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1521-6942(03)00041-X","article-title":"Co-morbidity in rheumatoid arthritis","volume":"17","author":"Mikuls","year":"2003","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/ar1814","article-title":"Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis","volume":"7","author":"Giles","year":"2005","journal-title":"Arthritis Research & Therapy"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib39","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","article-title":"Rheumatoid arthritis and cancer risk","volume":"32A","author":"Mellemkjaer","year":"1996","journal-title":"European Journal of Cancer"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard.2004.033993","article-title":"Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib42","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 PERSON-YEARS of observation","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib44","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"supplement","key":"10.1016\/j.berh.2007.06.002_bib45","first-page":"S188","article-title":"Inflammatory activity, but not methotrexate or prednisone use predicts non_Hodgkin's lymphoma in rheumatoid arthritis","volume":"41","author":"Wolfe","year":"1998","journal-title":"Arthritis and Rheumatism"},{"issue":"7152","key":"10.1016\/j.berh.2007.06.002_bib46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","article-title":"Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study","volume":"317","author":"Baecklund","year":"1998","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib47","first-page":"958","article-title":"National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, other rheumatic conditions: a 20 year followup study","volume":"30","author":"Thomas","year":"2003","journal-title":"The Journal of Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib48","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D","article-title":"A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals","volume":"42","author":"Karlson","year":"1999","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib49","first-page":"47","article-title":"Current tobacco smoking, formal education, the risk of rheumatoid arthritis","volume":"26","author":"Uhlig","year":"1999","journal-title":"The Journal of Rheumatology"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib50","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.1780401106","article-title":"Blood transfusion, smoking, obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England","volume":"40","author":"Symmons","year":"1997","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0010-7824(87)90082-5","article-title":"Oral contraceptives, cigarette smoking and other factors in relation to arthritis","volume":"35","author":"Vessey","year":"1987","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199007000-00005","article-title":"Reproductive factors, smoking, the risk for rheumatoid arthritis","volume":"1","author":"Hernandez Avila","year":"1990","journal-title":"Epidemiology (Cambridge, Mass.)"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib53","first-page":"1830","article-title":"Smoking and risk of rheumatoid arthritis","volume":"20","author":"Heliovaara","year":"1993","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01830241","article-title":"Recency, duration, progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA)","volume":"5","author":"Voigt","year":"1994","journal-title":"Cancer Causes & Control"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib55","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.1780390504","article-title":"Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins","volume":"39","author":"Silman","year":"1996","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib56","first-page":"630","article-title":"The effect of smoking on clinical, laboratory, radiographic status in rheumatoid arthritis","volume":"27","author":"Wolfe","year":"2000","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/ard.60.3.223","article-title":"Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA","volume":"60","author":"Hutchinson","year":"2001","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe","year":"1994","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib59","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/30.3.214","article-title":"High definition computed tomography in rheumatoid arthritis associated pulmonary disease","volume":"30","author":"Fewins","year":"1991","journal-title":"British Journal of Rheumatology"},{"issue":"2 Pt 1","key":"10.1016\/j.berh.2007.06.002_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/rheumatology\/33.2.118","article-title":"High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease","volume":"33","author":"McDonagh","year":"1994","journal-title":"British Journal of Rheumatology"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"56","author":"Cortet","year":"1997","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/ajrccm.161.1.9906062","article-title":"Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study","volume":"161","author":"Hubbard","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00063198-200409000-00017","article-title":"Cancer and interstitial lung disease","volume":"10","author":"Artinian","year":"2004","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib66","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2004.030528","article-title":"Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas","volume":"64","author":"Geborek","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.2005.044784","article-title":"Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis","volume":"65","author":"Franklin","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/kel303","article-title":"Lymphoma and rheumatoid arthritis\u2013again","volume":"46","author":"Symmons","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.berh.2007.06.002_bib69","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.22056","article-title":"Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis","volume":"54","author":"Setoguchi","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"19","key":"10.1016\/j.berh.2007.06.002_bib70","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"The Journal of the American Medical Association"},{"issue":"19","key":"10.1016\/j.berh.2007.06.002_bib71","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1158\/1078-0432.CCR-04-0730","article-title":"A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer","volume":"10","author":"Madhusudan","year":"2004","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jtbi.2000.2249","article-title":"Hypothesis: gonadal hormones act as confounders in epidemiological studies of the associations between some behavioural risk factors and some pathological conditions","volume":"209","author":"James","year":"2001","journal-title":"Journal of Theoretical Biology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas","year":"2000","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib74","first-page":"551","article-title":"Low incidence of colorectal cancer in patients with rheumatoid arthritis","volume":"14","author":"Kauppi","year":"1996","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2007.06.002_bib75","unstructured":"Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a Large U.S. Observational Study. Arthritis and Rheumatism in press."},{"issue":"6899","key":"10.1016\/j.berh.2007.06.002_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.307.6899.285","article-title":"Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme","volume":"307","author":"Logan","year":"1993","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","article-title":"The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force","volume":"146","author":"Dube","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","article-title":"Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement","volume":"146","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"9573","key":"10.1016\/j.berh.2007.06.002_bib79","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib80","first-page":"2130","article-title":"Skin cancer, rheumatoid arthritis, tumor necrosis factor inhibitors","volume":"32","author":"Chakravarty","year":"2005","journal-title":"The Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.282.2.153","article-title":"Prevalence of carpal tunnel syndrome in a general population","volume":"282","author":"Atroshi","year":"1999","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.berh.2007.06.002_bib82","doi-asserted-by":"crossref","DOI":"10.1080\/03009740601153774","article-title":"Rheumatoid arthritis treatment and the risk of severe interstitial lung disease","author":"Wolfe","year":"2007","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1378\/chest.93.1.114","article-title":"Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis","volume":"93","author":"Hakala","year":"1988","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib84","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/rheumatology\/41.6.676","article-title":"The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis","volume":"41","author":"Hubbard","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.berh.2007.06.002_bib85","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thx.35.7.496","article-title":"Cryptogenic fibrosing alveolitis and lung cancer","volume":"35","author":"Turner-Warwick","year":"1980","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib86","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.2005.043877","article-title":"Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia","volume":"65","author":"Atkins","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.40.2.136","article-title":"Relationship of gold and penicillamine therapy to diffuse interstitial lung disease","volume":"40","author":"Scott","year":"1981","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib89","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0049-0172(87)90022-9","article-title":"Gold lung: recent developments in pathogenesis, diagnosis, therapy","volume":"16","author":"Evans","year":"1987","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00296-003-0293-4","article-title":"Fatal, gold-induced pneumonitis","volume":"23","author":"Soler","year":"2003","journal-title":"Rheumatology International"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/rheumatology\/25.2.193","article-title":"European League against rheumatism study of adverse reactions to D-penicillamine","volume":"25","author":"Kay","year":"1986","journal-title":"British Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib92","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/23.3.220","article-title":"Diffuse alveolitis on a small dose of penicillamine","volume":"23","author":"Shettar","year":"1984","journal-title":"British Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib93","first-page":"406","article-title":"Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis","volume":"10","author":"Wolfe","year":"1983","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10067-003-0848-5","article-title":"Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis","volume":"23","author":"Ulubas","year":"2004","journal-title":"Clinical Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib95","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1378\/chest.101.4.1033","article-title":"Sulfasalazine-induced pulmonary disease","volume":"101","author":"Hamadeh","year":"1992","journal-title":"Chest"},{"issue":"3\u20134","key":"10.1016\/j.berh.2007.06.002_bib96","first-page":"153","article-title":"Sulphasalazine-induced eosinophilic pneumonia","volume":"41","author":"Timmer","year":"1992","journal-title":"The Netherlands Journal of Medicine"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib97","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarcon","year":"1997","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib98","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0889-857X(05)70366-5","article-title":"Methotrexate pulmonary toxicity","volume":"23","author":"Cannon","year":"1997","journal-title":"Rheumatic Diseases Clinics of North America"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib99","first-page":"51","article-title":"Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate","volume":"21","author":"Carroll","year":"1994","journal-title":"The Journal of Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0011-5029(94)90025-6","article-title":"Drug-induced pulmonary disease","volume":"40","author":"Rosenow","year":"1994","journal-title":"Disease-A-Month"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib101","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1378\/chest.104.5.1620","article-title":"Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings","volume":"104","author":"Leduc","year":"1993","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib102","first-page":"110","article-title":"Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature","volume":"15","author":"Green","year":"1988","journal-title":"The Journal of Rheumatology"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib103","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/art.1780261015","article-title":"Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis","volume":"26","author":"Cannon","year":"1983","journal-title":"Arthritis and Rheumatism"},{"issue":"9407","key":"10.1016\/j.berh.2007.06.002_bib104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","article-title":"Japan deaths spark concerns over arthritis drug","volume":"363","author":"McCurry","year":"2004","journal-title":"Lancet"},{"issue":"9416","key":"10.1016\/j.berh.2007.06.002_bib105","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(04)15969-2","article-title":"Interstitial lung disease and disease modifying anti-rheumatic drugs","volume":"363","author":"Scott","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib106","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009740410005836","article-title":"Severe interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Chatterjee","year":"2004","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib107","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.10803","article-title":"Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"47","author":"Kramer","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.11187","article-title":"Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis","volume":"49","author":"Courtney","year":"2003","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib109","first-page":"622","article-title":"Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis","volume":"33","author":"Ostor","year":"2006","journal-title":"The Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2007.06.002_bib111","unstructured":"Committee on safety of medicines. Methotrexate and pneumonitis. 5. Medicines and Healthcare products Regulatory Agency; 2003."},{"issue":"5 Suppl. 35","key":"10.1016\/j.berh.2007.06.002_bib112","first-page":"S95","article-title":"Benefit\/risk of leflunomide in rheumatoid arthritis","volume":"22","author":"Kremer","year":"2004","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib113","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ageing\/4.1.8","article-title":"Skinfold thickness on the dorsum of the hand in the elderly","volume":"4","author":"Roberts","year":"1975","journal-title":"Age\u00a0and Ageing"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7326\/0003-4819-131-2-199907200-00015","article-title":"Arthritis and I","volume":"131","author":"Bendor","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib115","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/ard.2005.048934","article-title":"Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions","volume":"65","author":"Douglas","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"13","key":"10.1016\/j.berh.2007.06.002_bib116","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib117","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib118","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archopht.116.2.219","article-title":"Incidence of age-related cataract: the Beaver Dam Eye Study","volume":"116","author":"Klein","year":"1998","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib119","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0161-6420(92)31934-7","article-title":"Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003685.pub2","article-title":"Rofecoxib for rheumatoid arthritis","author":"Garner","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1016\/j.berh.2007.06.002_bib121","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.berh.2007.06.002_bib122","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"The Journal of the American Medical Association"},{"issue":"9196","key":"10.1016\/j.berh.2007.06.002_bib123","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.berh.2007.06.002_bib124","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","article-title":"Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor","volume":"95","author":"Goldstein","year":"2000","journal-title":"The American Journal of Gastroenterology"},{"issue":"20","key":"10.1016\/j.berh.2007.06.002_bib125","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.282.20.1929","article-title":"Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs","volume":"282","author":"Langman","year":"1999","journal-title":"The Journal of the American Medical Association"},{"issue":"7119","key":"10.1016\/j.berh.2007.06.002_bib126","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.315.7119.1333","article-title":"Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study","volume":"315","author":"MacDonald","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"13","key":"10.1016\/j.berh.2007.06.002_bib127","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archinte.155.13.1371","article-title":"Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study","volume":"155","author":"Lanza","year":"1995","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/1999\/361651","article-title":"The epidemiology of nonsteroidal anti-inflammatory drugs","volume":"13","author":"Tenenbaum","year":"1999","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1440-1746.1991.tb00885.x","article-title":"Non-steroid anti-inflammatory drug associated ulcer: epidemiology, causation and treatment","volume":"6","author":"Langman","year":"1991","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/ar146","article-title":"The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, combinations of these agents","volume":"3","author":"Garcia Rodriguez","year":"2001","journal-title":"Arthritis Research"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib131","first-page":"204","article-title":"Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial","volume":"28","author":"Simon","year":"1996","journal-title":"Family Medicine"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib132","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780370806","article-title":"Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs","volume":"37","author":"Hayllar","year":"1994","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib133","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.berh.2007.06.002_bib134","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/ard.2003.010355","article-title":"Steroids, non-steroidal anti-inflammatory drugs, sigmoid diverticular abscess perforation in rheumatic conditions","volume":"63","author":"Mpofu","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib135","first-page":"1935","article-title":"Sigmoid diverticular abscess perforation in 2 patients with rheumatoid arthritis treated with high dose corticosteroids. A cautionary tale","volume":"28","author":"Hutchinson","year":"2001","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib136","first-page":"79","article-title":"Diverticulosis\u2013a primary cause of life-threatening complications in rheumatoid arthritis","volume":"13","author":"Myllykangas-Luosujarvi","year":"1995","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib137","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/gast.2003.50054","article-title":"Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use","volume":"124","author":"Laine","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2007.06.002_bib138","series-title":"Nutritional anemias: report of a WHO scientific group","author":"World Health Organization","year":"1968"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib139","first-page":"1516","article-title":"Anemia and renal function in patients with rheumatoid arthritis","volume":"33","author":"Wolfe","year":"2006","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/ard.2006.057265","article-title":"Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis","volume":"66","author":"Franklin","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"supplement 1","key":"10.1016\/j.berh.2007.06.002_bib141","first-page":"44","article-title":"Mortality in rheumatoid arthritis","volume":"27","author":"Symmons","year":"1988","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib142","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/rheumatology\/23.2.92","article-title":"Cause of death in rheumatoid arthritis","volume":"23","author":"Prior","year":"1984","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib143","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/03009748209098167","article-title":"Increased mortality in rheumatoid arthritis","volume":"11","author":"Allebeck","year":"1982","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib144","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/03009747709095458","article-title":"Death rate and causes of death in RA patients during a period of five years","volume":"6","author":"Koota","year":"1977","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009747509165257","article-title":"Death rate and causes of death in patients with rheumatoid arthritis","volume":"4","author":"Isomaki","year":"1975","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib146","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","article-title":"Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib147","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"18","key":"10.1016\/j.berh.2007.06.002_bib148","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/jama.296.18.2201-a","article-title":"Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis","volume":"296","author":"Costenbader","year":"2006","journal-title":"The Journal of the American Medical Association"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib149","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2007.06.002_bib150","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib151","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib152","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.21382","article-title":"Tuberculosis associated with therapy against tumor necrosis factor alpha","volume":"52","author":"Winthrop","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"7","key":"10.1016\/j.berh.2007.06.002_bib153","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"Askling","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"15","key":"10.1016\/j.berh.2007.06.002_bib154","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"supplement","key":"10.1016\/j.berh.2007.06.002_bib156","first-page":"33","article-title":"What are the risks of biologic therapy in rheumatoid arthritis? An update on safety","volume":"65","author":"Weisman","year":"2002","journal-title":"The Journal of Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2007.06.002_bib157","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/ard.2004.024737","article-title":"Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety","volume":"63","author":"Hyrich","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib158","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.berh.2007.06.002_bib159","first-page":"2025","article-title":"Depression is not more common in rheumatoid arthritis: a 10-year longitudinal study of 6153 patients with rheumatic disease","volume":"20","author":"Hawley","year":"1993","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib160","first-page":"1013","article-title":"Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis","volume":"32","author":"Ang","year":"2005","journal-title":"The Journal of Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2007.06.002_bib161","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2007.06.002_bib162","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"van Staa","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib163","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.5650100212","article-title":"Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group","volume":"10","author":"Lane","year":"1995","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.berh.2007.06.002_bib164","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.53.1.18","article-title":"Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis\u2013a population based study","volume":"53","author":"Kroger","year":"1994","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2007.06.002_bib165","first-page":"2582","article-title":"A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian study group on bone mass in rheumatoid arthritis","volume":"27","author":"Sinigaglia","year":"2000","journal-title":"The Journal of Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2007.06.002_bib166","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","article-title":"Epidemiology of osteoporosis in rheumatic diseases","volume":"32","author":"Sinigaglia","year":"2006","journal-title":"Rheumatic Diseases Clinics of North America"},{"issue":"6","key":"10.1016\/j.berh.2007.06.002_bib167","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/art.22350","article-title":"Osteoporosis management in patients with rheumatoid arthritis: evidence for improvement","volume":"55","author":"Solomon","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1016\/j.berh.2007.06.002_bib168","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"2\u20133","key":"10.1016\/j.berh.2007.06.002_bib169","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"International Journal of Cardiology"},{"issue":"25","key":"10.1016\/j.berh.2007.06.002_bib170","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.berh.2007.06.002_bib171","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694207000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694207000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T22:56:16Z","timestamp":1546556176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694207000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":171,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1521694207000769"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2007.06.002","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}